Altimmune, Inc.
ALT
$7.03
$0.253.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.72% | -7.48% | -31.93% | -24.64% | -8.68% |
| Total Depreciation and Amortization | 119.14% | 129.10% | 167.87% | -357.63% | -267.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.91% | -51.70% | 148.13% | 174.30% | 132.61% |
| Change in Net Operating Assets | 0.00% | 154.12% | 142.86% | 284.94% | -120.26% |
| Cash from Operations | -10.41% | -5.33% | -2.00% | -0.48% | -6.27% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 102.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.43% | -306.01% | -319.61% | -569.35% | 34.75% |
| Cash from Investing | 115.44% | -306.71% | -320.43% | -555.74% | 34.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.81% | -87.48% | 415.36% | 61.20% | 60.20% |
| Repurchase of Common Stock | 18.53% | 16.99% | 20.41% | 29.42% | -13.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -182.24% | -- | -100.00% | -100.00% | 267.03% |
| Cash from Financing | -48.43% | -88.34% | 446.39% | 63.10% | 61.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.21% | -508.67% | -36.39% | -35.00% | 65.84% |